NEAT1 and Alzheimer disease: Interestingly, the study revealed that plasma levels of NEAT1 are able to distinguish MCI and advanced-AD from healthy controls, indicating that this lncRNA may represent a biomarker for AD diagnosis, as previously observed in the brain tissue of AD post-mortem patients [102] and in animal models of AD [103].